A DirEct to PatieNt Study in Chronic Pain

Description

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Conditions

Chronic Pain

Talk to us

Study Overview

On this page

Study Details

Study overview

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

A DirEct to PatieNt Study in Chronic Pain

A DirEct to PatieNt Study in Chronic Pain

Condition
Chronic Pain
Intervention / Treatment

-

Contacts and Locations

Valencia

Boston Scientific Neuromodulation, Valencia, California, United States, 91355

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
  • * Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
  • * Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English
  • * Requires a legal representative to sign the ICF ascertained from self-reporting

Ages Eligible for Study

22 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Boston Scientific Corporation,

Natalie B Lyons, STUDY_DIRECTOR, Boston Scientific Corporation

Study Record Dates

2029-12